Can Angiosarcoma Be Treated?

Vascular sarcoma is a rare and aggressive malignancy arising from endothelial cells lining blood or lymphatic vessels. While challenging to treat due to its propensity for early metastasis and resistance to conventional therapies, vascular sarcoma is not uniformly untreatable—management depends heavily on tumor location, stage at diagnosis, histologic grade, and molecular characteristics.

Localized disease—particularly cutaneous or superficial soft-tissue variants—may be curable with wide local excision, often followed by adjuvant radiotherapy to reduce local recurrence risk. For deeper or visceral tumors (e.g., liver, breast, or heart), surgical resection remains the cornerstone of potentially curative treatment, though complete resection is frequently limited by anatomic constraints or multifocal involvement.

Systemic therapy plays a critical role in advanced or metastatic disease. Anthracycline-based regimens (e.g., doxorubicin alone or combined with ifosfamide) are commonly used first-line cytotoxic options, though response rates remain modest. Emerging evidence supports the use of paclitaxel—particularly in angiosarcomas associated with chronic lymphedema or radiation exposure—due to its anti-angiogenic and direct cytotoxic effects on endothelial-derived tumor cells.

Targeted agents and immunotherapies are under active investigation. While no targeted therapy is yet FDA-approved specifically for vascular sarcoma, case series and early-phase trials suggest potential activity for tyrosine kinase inhibitors (e.g., pazopanib, sorafenib) and immune checkpoint inhibitors (e.g., pembrolizumab), especially in tumors expressing PD-L1 or harboring specific genomic alterations such as MYC amplification or KDR mutations.

Multidisciplinary care—including input from surgical oncology, medical oncology, radiation oncology, and pathology—is essential for optimal decision-making. Enrollment in clinical trials is strongly encouraged, given the rarity of the disease and the urgent need for more effective, biologically rational treatments.